Upcoming Live Webinar | Large-Molecule Drugs Are Reshaping Drug Delivery | Register Now

Strategic Assessment for Portfolio Expansion of an Animal Health Pharma Company

Strategic Assessment for Portfolio Expansion of an Animal Health Pharma Company

A global animal health pharmaceutical client engaged Stellarix to gain end-to-end visibility into the nsMRA landscape relevant to feline chronic kidney disease (CKD). Our actionable intelligence enabled the firm to strengthen its competitive position by expanding its portfolio, streamlining partner shortlisting & prioritizing, and identifying market gaps. Client Background: A global animal health pharmaceutical company […]

Navigating Global Regulatory Challenges in Pharma: 2025 and Beyond

Global Regulatory Challenges in Pharma

The pharmaceutical industry is one of the most regulated industries in the world. The regulatory environment is changing rapidly as we approach 2026 due to progress in drug development, changes in digital health technologies, and other implications of geopolitical changes. Companies must deal with intricate compliance obligations, global interoperability, and emerging trends in their regulated […]

Pharma’s Eco Pill- Sustainable Packaging

Pharma's Eco Pill

Given the growing environmental issues, the pharmaceutical industry is facing increasing pressure to implement sustainable practices. One major area of emphasis is packaging. Most conventional medicinal packaging has been deemed incongruous due to environmental concerns, including its high plastic content and use of non-recyclable materials. The management of packaging waste is now one of the […]

Technology Overview & Start-up Scouting for Development of Allogeneic iPSCs

Development of Allogeneic iPSC

A clinical-stage biopharmaceutical company approached Stellarix to get a technology and innovation overview in the allogeneic iPSCs segment. Our strategic intelligence helped the client gain a future outlook on allogeneic iPSCs development with HLA/MHC knockdown, reforming its market and business strategy. Client Background: Clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent […]

Trump’s Pharma Tariffs: Risks, Impact & Strategy

Trump’s Pharma Tariffs

This is not a recent development; it started with the end of Trump’s first term. During the last quarter, executive orders were issued to cut down the costs of medicines. However, the federal court dismissed the motion, citing that this motion didn’t involve public opinion. The Biden administration also attempted it with the IRA when […]

IP Landscape- Lipid Nanoparticles for Biomolecules Delivery

lipid composition for biomolecule delivery

A global pharmaceutical leader partnered with Stellarix to gain strategic insights into lipid nanoparticle (LNP) systems for biomolecule delivery. With LNPs emerging as a critical platform for mRNA, siRNA, and CRISPR-based therapeutics, recognized and regulated by the FDA—our case study mapped key components, formulation strategies, and advanced manufacturing practices. Client Background: The client is a […]

Bispecific Antibody-Drug Conjugates: Clinical Development and Future Directions

Bispecific Antibody-Drug

In the last decade, ADCs have been an emerging class of medical modalities to treat cancer by combining potent anti-cancer medicines (i.e., payloads) with monoclonal antibodies that deliver cancer medicines to the target cells. According to the market reports, the global ADC request size was valued at around 11.84 billion USD in 2024 and is […]

Threat and Opportunity Assessment for Pharmaceutical Products

Threat and Opportunity Assessment for Pharmaceutical Products

A pharmaceutical product is any drug product that is approved by the FDA or other county-specific regulators for the treatment of specific diseases after comprehensive research and clinical development to ensure its efficacy and safety in patients when administered at the recommended dose. Sales growth of marketed pharmaceutical products depends on multiple parameters, such as […]

Rx to OTC Switch: Overview, Regulatory Requirement and Potential Switch Candidates

Rx to OTC Switch

Rx-to-OTC switch is the transfer of prescription-based drugs to non-prescription or over-the-counter status. It is a highly regulated and rigorous process that allows consumers to have OTC access to certain medicines with a high safety margin and is effective in treating self-diagnosable conditions. Over-the-counter products are broadly classified into key categories based on their therapeutic […]

Landscape: Child Resistant Packaging

A startup engaged with Stellarix to learn more about the child-resistant (CR) packaging market, technological advancement, size, trends, and regulations of the landscape. It requested that the CR packaging segment be explored, as well as emerging innovations and major players participating in the sector. The study provided the client with important insights that helped the […]